MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SYRS
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Syros Pharmaceuticals (SYRS) Ownership - Who owns Syros Pharmaceuticals?

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.37K
P/E Ratio
N/A
Total Cash
165.98M
Projected Growth
N/A
Total Debt
60.23M
Revenue
386K
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
6.19
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SYRS
A.I. Advisor
published General Information

General Information

a therapeutics company focusing on discovering and developing novel gene control therapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A